Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 3 Sarcoma 2 Prostatic Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Melanoma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Somatostatinoma 1 Solitary Fibrous Tumor, Pleural 1 Primary Myelofibrosis 1 Pheochromocytoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroendocrine Tumors 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Metastatic Non-hematologic Malignancies 1 Meningioma 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

lutetium Lu 177 dotatate 29 Everolimus 19 Temozolomide 11 gallium Ga 68 dotatate 10 Nivolumab 10 Magnetic Resonance Spectroscopy 10 Capecitabine 9 pembrolizumab 8 lanreotide 8 Positron Emission Tomography Computed Tomography 8 cabozantinib 7 3-Iodobenzylguanidine 7 177Lu-octreotide, DOTA(0)-Tyr(3)- 7 Somatostatin 6 90Y-octreotide, DOTA-Tyr(3)- 6 telotristat ethyl 5 lenvatinib 5 Octreotide 5 Lutetium-177 5 Ga(III)-DOTATOC 5 Fluorodeoxyglucose F18 5 Carboplatin 5 avelumab 4 Positron-Emission Tomography 4 Ipilimumab 4 Bevacizumab 4 surufatinib 3 pasireotide 3 fluorodopa F 18 3 copper dotatate CU-64 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroendocrine Tumors × vatalanib × Clear all

NCT00590343 2011-06-29

PTK787

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡